UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway

JAMA : the journal of the American Medical Association, 2023-03, Vol.329 (9), p.760

2023

Volltextzugriff (PDF)

Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval

JAMA internal medicine, 2021-12, Vol.181 (12), p.1673

2021

Volltextzugriff (PDF)

Newly approved cancer drugs in China - innovation and clinical benefit

Nature reviews. Clinical oncology, 2023-03, Vol.20 (3), p.135-136

2023

Volltextzugriff (PDF)

Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis

The lancet oncology, 2024-06, Vol.25 (6), p.760-769

2024

Volltextzugriff (PDF)

Essential medicines for universal health coverage

The Lancet (British edition), 2017-01, Vol.389 (10067), p.403-476

2017

Volltextzugriff (PDF)

Simulation-based power calculation for designing interrupted time series analyses of health policy interventions

Journal of clinical epidemiology, 2011-11, Vol.64 (11), p.1252-1261

2011

Volltextzugriff (PDF)

Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs

JAMA internal medicine, 2021-11, Vol.181 (11), p.1521

2021

Volltextzugriff (PDF)

Efficacy and costs of spinal muscular atrophy drugs

Science translational medicine, 2020-11, Vol.12 (569)

2020

Volltextzugriff (PDF)

Payers’ experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia

Health policy (Amsterdam), 2017-04, Vol.121 (4), p.354-362

2017

Volltextzugriff (PDF)

The impact of speech type on listening effort and intelligibility for native and non-native listeners

Frontiers in neuroscience, 2023-09, Vol.17, p.1235911-1235911

2023

Volltextzugriff (PDF)

Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage

Canadian Medical Association journal (CMAJ), 2017-06, Vol.189 (23), p.E794-E799

2017

Volltextzugriff (PDF)

Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States

International journal of cancer, 2022-02, Vol.150 (3), p.482-490

2022

Volltextzugriff (PDF)

Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment

Journal of clinical oncology, 2018-04, Vol.36 (11), p.1121-1127

2018

Volltextzugriff (PDF)

Policies and programs to facilitate access to targeted cancer therapies in Thailand

PloS one, 2015-03, Vol.10 (3), p.e0119945-e0119945

2015

Volltextzugriff (PDF)

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand

BMC health services research, 2020-04, Vol.20 (1), p.351-351, Article 351

2020

Volltextzugriff (PDF)

Methods for estimating confidence intervals in interrupted time series analyses of health interventions

Journal of clinical epidemiology, 2009-02, Vol.62 (2), p.143-148

2009

Volltextzugriff (PDF)

The Cochlear Implant EEG Artifact Recorded From an Artificial Brain for Complex Acoustic Stimuli

IEEE transactions on neural systems and rehabilitation engineering, 2018-02, Vol.26 (2), p.392-399

2018

Volltextzugriff (PDF)

Quality use of medicines within universal health coverage: challenges and opportunities

BMC health services research, 2014-08, Vol.14 (1), p.357-357, Article 357

2014

Volltextzugriff (PDF)

The Timing and Effort of Lexical Access in Natural and Degraded Speech

Frontiers in psychology, 2016-03, Vol.7, p.398-398

2016

Volltextzugriff (PDF)

Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018

JAMA internal medicine, 2021-12, Vol.181 (12), p.1596

2021

Volltextzugriff (PDF)

Do Musicians and Non-musicians Differ in Speech-on-Speech Processing?

Frontiers in psychology, 2021-02, Vol.12, p.623787-623787

2021

Volltextzugriff (PDF)

Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer

Value in health, 2024-09, Vol.27 (9), p.1175-1178

2024

Volltextzugriff (PDF)

Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe

BMJ (Online), 2023-03, Vol.380, p.e073711

2023

Volltextzugriff (PDF)

Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries

Health policy and planning, 2015-10, Vol.30 (8), p.1044-1052

2015

Volltextzugriff (PDF)

Individual Variations in Effort: Assessing Pupillometry for the Hearing Impaired

Trends in hearing, 2019-05, Vol.23, p.2331216519845596

2019

Volltextzugriff (PDF)

1 – 25 von 608

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(516)
Mit Volltextzugriff
(528)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(384)
Life Sciences & Biomedicine
(326)
Humans
(240)
Female
(115)
Adult
(90)
Male
(89)
Middle Aged
(73)
Neurosciences & Neurology
(63)
Neurosciences
(62)
Medicine, Research & Experimental
(59)
Otorhinolaryngology
(59)
Research & Experimental Medicine
(59)
Aged
(55)
Biology
(51)
Life Sciences & Biomedicine - Other Topics
(51)
Biological And Medical Sciences
(46)
Health Care Sciences & Services
(46)
Technology
(44)
Public, Environmental & Occupational Health
(41)
Medical Sciences
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway

Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval

Newly approved cancer drugs in China - innovation and clinical benefit

Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis

Essential medicines for universal health coverage

Simulation-based power calculation for designing interrupted time series analyses of health policy interventions

Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs

Efficacy and costs of spinal muscular atrophy drugs

Payers’ experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia

The impact of speech type on listening effort and intelligibility for native and non-native listeners

Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage

Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States

Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment

Policies and programs to facilitate access to targeted cancer therapies in Thailand

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand

Methods for estimating confidence intervals in interrupted time series analyses of health interventions

The Cochlear Implant EEG Artifact Recorded From an Artificial Brain for Complex Acoustic Stimuli

Quality use of medicines within universal health coverage: challenges and opportunities

The Timing and Effort of Lexical Access in Natural and Degraded Speech

Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018

Do Musicians and Non-musicians Differ in Speech-on-Speech Processing?

Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer

Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe

Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries

Individual Variations in Effort: Assessing Pupillometry for the Hearing Impaired

Suchergebnisse filtern